坚持创新驱动 让中国品牌“走出去”

Core Insights - The eighth "Belt and Road" Traditional Chinese Medicine (TCM) Development Forum and the third OTC Brand Conference were held in Hangzhou, focusing on high-quality development in the context of the Belt and Road Initiative [2] - The forum aimed to create a high-quality platform for international exchange in TCM and OTC brands, emphasizing the integration of government, industry, academia, research, and application [2] - The OTC market in China is projected to exceed 300 billion yuan by 2024, with a compound annual growth rate of 4.6% from 2018 to 2024 [3] Group 1 - The forum gathered representatives from various countries, international organizations, regulatory bodies, industry leaders, and experts to discuss TCM innovation and the upgrading of OTC brands [2] - The president of the China Non-Prescription Drug Association highlighted the importance of TCM and the OTC industry in promoting high-quality development and public health [2] - Bayer's general manager emphasized the need for patient-centered policies that enhance product accessibility and understanding [2] Group 2 - The demand for TCM has shifted from "treating illness" to "daily health management," with consumers increasingly focusing on preventive care and wellness [3] - There are three emerging opportunities in the TCM industry: increased attention to niche categories, a rise in service-oriented consumption, and the integration of online and offline channels for consumer engagement [3] - The association aims to promote the healthy development of the OTC industry and enhance the global presence of Chinese OTC and TCM brands [3]